CD133-targeted delivery of self-assembled PEGylated carboxymethylcellulose-SN38 nanoparticles to colorectal cancer

References

• Siegel RL, Miller KD, Fedewa SA, et al. Colorectal cancer statistics, 2017. CA Cancer J Clin. 2017;67:177–193.
   PubMed Web of Science ®Google Scholar
• Fuchs C, Mitchell EP, Hoff PM. Irinotecan in the treatment of colorectal cancer. Cancer Treat Rev. 2006;32:491–503.
   PubMed Web of Science ®Google Scholar
• Peng C-L, Lai P-S, Lin F-H, et al. Dual chemotherapy and photodynamic therapy in an HT-29 human colon cancer xenograft model using SN-38-loaded chlorin-core star block copolymer micelles. Biomaterials. 2009;30:3614–3625.
   PubMed Web of Science ®Google Scholar
• Fang T, Dong Y, Zhang X, et al. Integrating a novel SN38 prodrug into the PEGylated liposomal system as a robust platform for efficient cancer therapy in solid tumors. Int J Pharm. 2016;512:39–48.
   PubMed Web of Science ®Google Scholar
• Lee S-Y, Yang C-Y, Peng C-L, et al. A theranostic micelleplex co-delivering SN-38 and VEGF siRNA for colorectal cancer therapy. Biomaterials. 2016;86:92–105.
   PubMed Web of Science ®Google Scholar
• Bala V, Rao S, Boyd BJ, et al. Prodrug and nanomedicine approaches for the delivery of the camptothecin analogue SN38. J Control Release. 2013;172:48–61.
   PubMed Web of Science ®Google Scholar
• Gu Q, Xing JZ, Huang M, et al. SN-38 loaded polymeric micelles to enhance cancer therapy. Nanotechnology. 2012;23:205101.
   PubMed Web of Science ®Google Scholar
• Ebrahimnejad P, Dinarvand R, Sajadi A, et al. Preparation and in vitro evaluation of actively targetable nanoparticles for SN-38 delivery against HT-29 cell lines. Nanomedicine. 2010;6:478–485.
   PubMed Web of Science ®Google Scholar
• Mosallaei N, Mahmoudi A, Ghandehari H, et al. Solid lipid nanoparticles containing 7-ethyl-10-hydroxycamptothecin (SN38): preparation, characterization, in vitro, and in vivo evaluations. Eur J Pharm Biopharm. 2016;104:42–50.
   PubMed Web of Science ®Google Scholar
• Goldberg DS, Vijayalakshmi N, Swaan PW, et al. G3. 5 PAMAM dendrimers enhance transepithelial transport of SN38 while minimizing gastrointestinal toxicity. J Control Release. 2011;150:318–325.
   PubMed Web of Science ®Google Scholar
• Duncan R. Development of HPMA copolymer-anticancer conjugates: clinical experience and lessons learnt. Adv Drug Deliv Rev. 2009;61:1131–1148.
   PubMed Web of Science ®Google Scholar
• Singer JW, Shaffer S, Baker B, et al. Paclitaxel poliglumex (XYOTAX; CT-2103): an intracellularly targeted taxane. Anticancer Drugs. 2005;16:243–254.
   PubMed Web of Science ®Google Scholar
• Avendaño C, Menéndez JC. Medicinal chemistry of anticancer drugs. Amsterdam: Elsevier; 2008. Drug targeting in anticancer chemotherapy; p. 351–385.
   Google Scholar
• Feng Q, Tong R. Anticancer nanoparticulate polymer‐drug conjugate. Bioeng Transl Med. 2016;1:277–296.
   PubMed Web of Science ®Google Scholar
• Hoang B, Ernsting MJ, Roy A, et al. Docetaxel-carboxymethylcellulose nanoparticles target cells via a SPARC and albumin dependent mechanism. Biomaterials. 2015;59:66–76.
   PubMed Web of Science ®Google Scholar
• Ajorlou E, Khosroushahi AY, Yeganeh H. Novel water-borne polyurethane nanomicelles for cancer chemotherapy: higher efficiency of folate receptors than TRAIL receptors in a Cancerous Balb/C Mouse Model. Pharm Res. 2016;33(6):1426–1439.
   PubMed Web of Science ®Google Scholar
• Jiang J, Chen H, Yu C, et al. The promotion of salinomycin delivery to hepatocellular carcinoma cells through EGFR and CD133 aptamers conjugation by PLGA nanoparticles. Nanomedicine. 2015;10(12):1863–1879.
   PubMed Web of Science ®Google Scholar
• Swaminathan SK, Roger E, Toti U, et al. CD133-targeted paclitaxel delivery inhibits local tumor recurrence in a mouse model of breast cancer. J Control Release. 2013;171(3):280–287.
   PubMed Web of Science ®Google Scholar
• Chen Y, Chen C, Xiao Y, et al. Liposomes Encapsulating 10-Hydroxycamptothecin-Cyclodextrin Complexes and Their In Vitro Anti-Tumor Activities. J. Nanosci Nanotechnol. 2015;15(5):3786–3795.
   PubMed Web of Science ®Google Scholar
• Shigdar S, Qiao L, Zhou S-F, et al. RNA aptamers targeting cancer stem cell marker CD133. Cancer Lett. 2013;330:84–95.
   PubMed Web of Science ®Google Scholar
• Ulasov IV, Nandi S, Dey M, et al. Inhibition of Sonic hedgehog and Notch pathways enhances sensitivity of CD133+ glioma stem cells to temozolomide therapy. Mol Med. 2011;17(1-2):103.
   PubMed Web of Science ®Google Scholar
• Ni M, Xiong M, Zhang X, et al. Poly (lactic-co-glycolic acid) nanoparticles conjugated with CD133 aptamers for targeted salinomycin delivery to CD133+ osteosarcoma cancer stem cells. Int J Nanomedicine. 2015;10:2537.
   PubMed Web of Science ®Google Scholar
• Mongelard F, Bouvet P. AS-1411, a guanosine-rich oligonucleotide aptamer targeting nucleolin for the potential treatment of cancer, including acute myeloid leukemia. Curr Opin Mol. 2010;12(1):107–114.
   Google Scholar
• Roy A, Murakami M, Ernsting MJ, et al. Carboxymethylcellulose-based and docetaxel-loaded nanoparticles circumvent P-glycoprotein-mediated multidrug resistance. Mol Pharm. 2014;11:2592–2599.
   PubMed Web of Science ®Google Scholar
• Zhang X, Jackson JK, Burt HM. Determination of surfactant critical micelle concentration by a novel fluorescence depolarization technique. J Biochem Biophys Methods. 1996;31:145–150.
   PubMedGoogle Scholar
• Mueller H, Kassack MU, Wiese M. Comparison of the usefulness of the MTT, ATP, and calcein assays to predict the potency of cytotoxic agents in various human cancer cell lines. J Biomol Screen. 2004;9:506–515.
   PubMed Web of Science ®Google Scholar
• Ernsting MJ, Tang W-L, MacCallum N, et al. Synthetic modification of carboxymethylcellulose and use thereof to prepare a nanoparticle forming conjugate of docetaxel for enhanced cytotoxicity against cancer cells. Bioconjugate Chem. 2011;22:2474–2486.
   PubMed Web of Science ®Google Scholar
• Patnaik A, Papadopoulos KP, Tolcher AW, et al. Phase I dose-escalation study of EZN-2208 (PEG-SN38), a novel conjugate of poly(ethylene) glycol and SN38, administered weekly in patients with advanced cancer. Cancer Chemother Pharmacol. 2013;71:1499–1506.
   PubMed Web of Science ®Google Scholar
• Lee H, Lee K, Park TG. Hyaluronic acid-paclitaxel conjugate micelles: synthesis, characterization, and antitumor activity. Bioconjug Chem. 2008;19:1319–1325.
   PubMed Web of Science ®Google Scholar
• Van S, Das SK, Wang X, et al. Synthesis, characterization, and biological evaluation of poly(L-gamma-glutamyl-glutamine)-paclitaxel nanoconjugate. Int J Nanomed. 2010;5:825–837.
   PubMed Web of Science ®Google Scholar
• Zhang H, Wang J, Mao W, et al. Novel SN38 conjugate-forming nanoparticles as anticancer prodrug: In vitro and in vivo studies. J Control Release. 2013;166(2):147–158.
   PubMed Web of Science ®Google Scholar
• Sahlberg SH, Spiegelberg D, Glimelius B, et al. Evaluation of cancer stem cell markers CD133, CD44, CD24: association with AKT isoforms and radiation resistance in colon cancer cells. PLos One. 2014;9:e94621.
   PubMed Web of Science ®Google Scholar
• Elsaba TMA, Martinez-Pomares L, Robins AR, et al. The stem cell marker CD133 associates with enhanced colony formation and cell motility in colorectal cancer. PLos One. 2010;5:e10714.
   PubMed Web of Science ®Google Scholar
• Alibolandi M, Taghdisi SM, Ramezani P, et al. Smart AS1411-aptamer conjugated pegylated PAMAM dendrimer for the superior delivery of camptothecin to colon adenocarcinoma in vitro and in vivo. Int J Pharm. 2017;519:352–364.
   PubMed Web of Science ®Google Scholar
• Taghavi S, Ramezani M, Alibolandi M, et al. Chitosan-modified PLGA nanoparticles tagged with 5TR1 aptamer for in vivo tumor-targeted drug delivery. Cancer Lett. 2017;400:1–8.
   PubMed Web of Science ®Google Scholar
• Alibolandi M, Mohammadi M, Taghdisi SM, et al. Fabrication of aptamer decorated dextran coated nano-graphene oxide for targeted drug delivery. Carbohydr Polym. 2017;155(Suppl C): 218–229.
   Web of Science ®Google Scholar
• Alibolandi M, Ramezani M, Abnous K, et al. AS1411 aptamer-decorated biodegradable polyethylene glycol-poly(lactic-co-glycolic acid) nanopolymersomes for the targeted delivery of gemcitabine to non-small cell lung cancer in vitro. J Pharm Sci. 2016;105:1741–1750.
   PubMed Web of Science ®Google Scholar
• Alibolandi M, Ramezani M, Abnous K, et al. In vitro and in vivo evaluation of therapy targeting epithelial-cell adhesion-molecule aptamers for non-small cell lung cancer. J Control Release. 2015;209:88–100.
   PubMed Web of Science ®Google Scholar